|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 396.8 CHF | -1.18% |
|
+0.13% | +30.03% |
| 06-12 | German Pharmaceutical Medac Picks Ypsomed Autoinjector for Methotrexate Pen Relaunch | MT |
| 05-22 | Ypsomed Holding AG Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Ypsomed Holding AG reported earnings results for the full year ended March 31, 2024. For the full year, the company reported net income was CHF 78.37 million compared to CHF 51.28 million a year ago. Basic earnings per share from continuing operations was CHF 5.74 compared to CHF 3.82 a year ago.
Diluted earnings per share from continuing operations was CHF 5.74 compared to CHF 3.82 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +30.03% | 6.15B | |
| -6.51% | 180B | |
| -3.57% | 106B | |
| -5.18% | 67.55B | |
| -5.68% | 46.11B | |
| +14.06% | 45.79B | |
| +2.58% | 41.61B | |
| +18.70% | 31.07B | |
| +11.40% | 24.77B | |
| -5.44% | 24.27B |
YPSOMED HOLDING AG 
